Tranexamic acid, controlled hypotension or their combination for reduction in bleeding due to craniocynostosis
Phase 3
- Conditions
- Bleeding during craniosynostosis.CraniosynostosisQ75.0
- Registration Number
- IRCT20190328043128N1
- Lead Sponsor
- Esfahan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 75
Inclusion Criteria
Physical status of I-II based on American Society of Anesthesiology
Age of 3 months to 12 months
Exclusion Criteria
Cardiac disease
Liver disease
Renal disease
Pulmonary disease
Congenital anomaly
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Amount of bleeding. Timepoint: During the surgery. Method of measurement: Gradient container contained suctioned blood.;The amount of transfused blood. Timepoint: During the surgery and admission at intensive care unit. Method of measurement: Pack cell.;The amount of transfused fresh frozen plasma. Timepoint: During the surgery and admission at intensive care unit. Method of measurement: Pack cell.
- Secondary Outcome Measures
Name Time Method